PL413052A1 - Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strains - Google Patents
Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strainsInfo
- Publication number
- PL413052A1 PL413052A1 PL413052A PL41305215A PL413052A1 PL 413052 A1 PL413052 A1 PL 413052A1 PL 413052 A PL413052 A PL 413052A PL 41305215 A PL41305215 A PL 41305215A PL 413052 A1 PL413052 A1 PL 413052A1
- Authority
- PL
- Poland
- Prior art keywords
- proteus mirabilis
- bacteriophage
- bacteriophage strain
- drug
- treatment
- Prior art date
Links
- 241001515965 unidentified phage Species 0.000 title abstract 7
- 241000588770 Proteus mirabilis Species 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 210000002421 cell wall Anatomy 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000002101 lytic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Przedmiotem wynalazku jest nowy szczep bakteriofagowy i jego zastosowanie do produkcji preparatów stosowanych w leczeniu lub zapobieganiu zakażeniom bakteryjnym i zwalczaniu biofilmów, zwłaszcza szczepami bakterii lekoopornych z gatunku Proteus mirabilis. Nowy szczep bakteriofaga specyficzny wobec bakterii należących do gatunku Proteus mirabilis jest zdeponowany w Polskiej Kolekcji Mikroorganizmów (PCM) pod numerem depozytowym: F/00084. Zastosowanie szczepu bakteriofaga dotyczy użycia całego bakteriofaga w preparatach złożonych z pojedynczego typu faga, jak i w postaci koktajlu zawierającego kilka lub kilkanaście aktywnych bakteriofagów. Ponadto wynalazek obejmuje wykorzystanie oczyszczonych białek bakteriofagowych, korzystnie enzymów litycznych degradujących ścianę komórkową bakterii oraz rozkładających bakteryjne polisacharydy zewnątrzkomórkowe.The subject of the invention is a new bacteriophage strain and its use in the production of preparations used in the treatment or prevention of bacterial infections and combating biofilms, especially strains of drug-resistant bacteria of the species Proteus mirabilis. A new bacteriophage strain specific for bacteria belonging to the species Proteus mirabilis is deposited in the Polish Collection of Microorganisms (PCM) under deposit number: F / 00084. The use of the bacteriophage strain refers to the use of the entire bacteriophage in preparations consisting of a single type of phage, as well as in the form of a cocktail containing several or several active bacteriophages. Furthermore, the invention includes the use of purified bacteriophage proteins, preferably lytic enzymes that degrade the bacterial cell wall and degrade bacterial extracellular polysaccharides.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413052A PL228856B1 (en) | 2015-07-07 | 2015-07-07 | Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strains |
| SI201630733T SI3319626T1 (en) | 2015-07-07 | 2016-07-07 | Bacteriophage strains against proteus mirabilis and uses thereof |
| PCT/IB2016/000974 WO2017006175A1 (en) | 2015-07-07 | 2016-07-07 | New bacteriophage strains against proteus mirabilis and use thereof |
| PL16753961T PL3319626T3 (en) | 2015-07-07 | 2016-07-07 | Bacteriophage strains against proteus mirabilis and uses thereof |
| US15/742,127 US10435671B2 (en) | 2015-07-07 | 2016-07-07 | Bacteriophage strains against proteus mirabilis and use thereof |
| DK16753961.8T DK3319626T3 (en) | 2015-07-07 | 2016-07-07 | Bacteriophage strains against Proteus mirabilis and their applications |
| EP16753961.8A EP3319626B1 (en) | 2015-07-07 | 2016-07-07 | Bacteriophage strains against proteus mirabilis and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413052A PL228856B1 (en) | 2015-07-07 | 2015-07-07 | Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL413052A1 true PL413052A1 (en) | 2017-01-16 |
| PL228856B1 PL228856B1 (en) | 2018-05-30 |
Family
ID=57756416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL413052A PL228856B1 (en) | 2015-07-07 | 2015-07-07 | Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strains |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL228856B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113980913A (en) * | 2021-11-08 | 2022-01-28 | 广西大学 | A Proteus mirabilis phage and its application |
-
2015
- 2015-07-07 PL PL413052A patent/PL228856B1/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113980913A (en) * | 2021-11-08 | 2022-01-28 | 广西大学 | A Proteus mirabilis phage and its application |
| CN113980913B (en) * | 2021-11-08 | 2023-12-15 | 广西大学 | Proteus mirabilis bacteriophage and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| PL228856B1 (en) | 2018-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019264537A1 (en) | Beta-lactamase inhibitors | |
| PH12019500714A1 (en) | Antiseptic-tolerant lactic acid bacteria | |
| ZA202002093B (en) | Antibacterial compounds | |
| WO2013184755A3 (en) | Seca inhibitors and methods of making and using thereof | |
| MX2018001075A (en) | Antibacterial therapeutics and prophylactics. | |
| NZ630117A (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
| MX2017012545A (en) | Heterocyclic compounds and their use in preventing or treating bacterial infections. | |
| MX2014001599A (en) | Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthy ridinones. | |
| UA111210C2 (en) | ANTIBACTERIAL 3,4-DIGIDRO-1H- [1,8] NAFTYRIDINONS, CYCLOPENT SUBSTITUTED [C] PYROM | |
| PH12018501575A1 (en) | Indolinones compounds and their use in the treatment of fibrotic diseases | |
| MX2020006191A (en) | Therapeutic bacteriocins. | |
| ZA202006612B (en) | Antibacterial compounds | |
| MX2015001834A (en) | New antibacterial compounds. | |
| MX2017012535A (en) | Novel heterocyclic compounds and their use in preventing or treating bacterial infections. | |
| MX2014001598A (en) | Antibacterial homopiperidinyl substituted 3,4 dihydro 1h [1,8]naphthyridinones. | |
| MX2022006109A (en) | 1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors. | |
| EA201890412A1 (en) | ANTIBACTERIAL AGENTS CONTAINING PIRAZINO [2,3-b] [1,4] OXAZIN-3-IT OR RELATED RING SYSTEM | |
| MX2017014080A (en) | Heterocyclic compounds and their use in preventing or treating bacterial infections. | |
| WO2013166282A3 (en) | Methods and compositions for treating bacterial infection | |
| AU2012335397A8 (en) | Novel bacteriophages | |
| PL386175A1 (en) | New strains of bacteriophages for treatment of bacterial infections, preferably by means of the strains of drug-resistant bacterias of the Enterococcus type | |
| MX363480B (en) | New antibacterial compounds. | |
| BR112021015638A2 (en) | Methods, compositions containing bacillus-producing bacteria or preparations thereof | |
| PH12021552133A1 (en) | Aromatic derivatives, preparation methods, and medical uses thereof | |
| PL413052A1 (en) | Bacteriophage strain and its application for treatment of infections caused by Proteus mirabilis bacteria, preferably by drug-resistant strains |